The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
Since antibody titers against Epstein-Barr virus (EBV) antigens are often elevated in sera of patient with active undifferentiated and nonkeratinizing nasopharyngeal carcinoma, anti-EBV serologic tests have been applied for diagnosis of metastatic lymphadenopathy in the neck without an obvious source and/or suspicious tumor of the nasopharynx. In this study it is emphasized that the serologic test procedure was helpful in diagnosing a patient with nasopharyngeal carcinoma that was initially occult but eventually confirmed by biopsy.
D000914:Antibodies, Viral / Q000032:analysis*; D002213:Capsid / Q000276:immunology; D002277:Carcinoma / Q000175:diagnosis* / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis* / Q000276:immunology
D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G